Subcutaneous Drug Delivery Device Market Trends and Forecast
The future of the global subcutaneous drug delivery device market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels. The global subcutaneous drug delivery device market is expected to reach an estimated $50 billion by 2030 with a CAGR of 11% from 2024 to 2030. The major drivers for this market are increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunization campaign.
Subcutaneous drug delivery devices are primarily constructed using medical-grade plastics such as polycarbonate and polypropylene for casing and reservoirs, ensuring durability and compatibility with sterilization processes. They also incorporate metals like stainless steel and titanium for needles and mechanical components, providing strength and biocompatibility essential for safe and effective drug administration. The price of subcutaneous drug delivery devices varies based on factors such as complexity, materials used, and technological features, often competing on cost-effectiveness and performance. Manufacturers strive to offer competitive pricing while maintaining high quality and meeting regulatory standards to meet the diverse needs of healthcare providers and patients.
• Lucintel forecasts that prefilled syringes will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost effectiveness, and high societal acceptance.
• Retail pharmacy is expected to remain the largest segment due to patients’ growing preference for physical pharmacies owing to quick availability of medication and expanding number of retail pharmacies.
• North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.
Country Wise Outlook for the Subcutaneous Drug Delivery Device Market
The subcutaneous drug delivery device market is indeed experiencing significant growth globally, fueled by increased demand from various industries such as pharmaceuticals, biotechnology, and healthcare, driven by the need for effective and convenient delivery of medications, including insulin and biologics. Below image highlights recent developments by major subcutaneous drug delivery device producers in key regions: the USA, Germany, China, Brazil, and India.
Emerging Trends in the Subcutaneous Drug Delivery Device Market
Emerging trends in the subcutaneous drug delivery device market shaping its future applications and market dynamics:
• Use of Subcutaneous Drug Delivery Devices: There is a growing trend towards the use of subcutaneous drug delivery devices for biologics and biosimilars. These include monoclonal antibodies, insulin, growth factors, and other complex molecules that require precise and controlled delivery to achieve therapeutic efficacy.
• Innovation in Subcutaneous Drug Delivery Technology: Biodegradable micropumps are another innovation in subcutaneous drug delivery technology. These pumps are implanted under the skin to deliver medications at controlled rates over time, gradually degrading in the body after completing their delivery function. They offer potential advantages for chronic disease management and targeted therapies.
• Focus on Customization and Personalization: There is an increasing focus on customizable and personalized drug delivery solutions to meet individual patient needs. Devices that allow for adjustable dosing, variable injection speed, and tailored treatment regimens are gaining attention in the market to optimize therapeutic outcomes and patient satisfaction.
• Adaption Regulatory Bodies: Regulatory bodies are adapting guidelines to accommodate advancements in subcutaneous drug delivery devices, ensuring safety, efficacy, and quality standards are met. This includes requirements for device usability, compatibility with different drug formulations, and robust manufacturing processes.
A more than 150 pages have been developed to help in your business decisions. Sample figures with some insights are shown below.
Recent Developments by the Subcutaneous Drug Delivery Device Market Suppliers
Recent developments in subcutaneous drug delivery device by various companies highlight ongoing innovations and advancements across different sectors:
• Advancements in Wearable Subcutaneous Drug Delivery Devices: Recent developments in the subcutaneous drug delivery device market include advancements in wearable devices for continuous drug delivery. Companies such as Medtronic and Insulet are developing wearable insulin pumps and continuous glucose monitoring (CGM) systems that integrate subcutaneous drug delivery with real-time monitoring and data analytics capabilities, enhancing diabetes management for patients.
• Introduction of Smart Injection Pens: Smart injection pens equipped with connectivity features and digital health tracking capabilities are gaining traction in the market. Companies like Novo Nordisk and Eli Lilly are launching smart injection pen devices that allow patients to track insulin doses, monitor injection sites, and receive reminders for medication adherence, improving patient engagement and treatment outcomes.
• Expansion of Subcutaneous Biologics Delivery Platforms: The subcutaneous drug delivery device market is witnessing an expansion of platforms for delivering biologic drugs. Companies like Amgen and Roche are developing innovative delivery systems, such as prefilled syringes, autoinjectors, and on-body infusors, for subcutaneous administration of biologic therapies targeting various diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions.
• Integration of Digital Health Solutions: Digital health solutions are being integrated into subcutaneous drug delivery devices to improve patient adherence, remote monitoring, and disease management. Companies like BD and West Pharmaceutical Services are collaborating with digital health platforms to develop connected drug delivery devices that enable data sharing between patients, healthcare providers, and caregivers, facilitating personalized treatment plans and remote support.
• Focus on Patient-Centric Design: Manufacturers are focusing on patient-centric design principles to enhance the usability, comfort, and safety of subcutaneous drug delivery devices. Human factors engineering and patient feedback are guiding the development of devices with features such as ergonomic grips, intuitive user interfaces, and needle safety mechanisms, ensuring a positive user experience and minimizing the risk of errors or adverse events.
• Regulatory Approvals for Novel Subcutaneous Drug Delivery Technologies: Regulatory agencies such as the FDA and EMA are granting approvals for novel subcutaneous drug delivery technologies, paving the way for market expansion and adoption. Recent approvals include innovative devices for delivering biologic therapies, long-acting injectable medications, and patient-controlled infusion systems, providing patients with more options for managing their health conditions safely and effectively.
Strategic Growth Opportunities for Subcutaneous Drug Delivery Device Market
The subcutaneous drug delivery device market is very dynamic due to its unique properties of being versatile in application, pivotal for chronic disease management, and crucial for enhancing patient compliance and therapeutic efficacy across diverse healthcare settings.
Some key strategic growth opportunities for this market include:
Technological Advancements:
• For instance, breakthroughs in device technologies such as microneedles, wearable injectors and auto injectors are continuously expanding the potential of subcutaneous drug delivery systems. This is making it easier for patients to take their medications while on the go and in need of fast action, reducing pain experienced during administration and enhancing accuracy as well as control in administering drugs which makes them saleable.
Rising Chronic Disease Burden:
• The burden of chronic diseases like diabetes, autoimmune disorders and cardiovascular conditions is increasing globally. Therefore, the use of subcutaneous drug delivery systems can be quite reliable when delivering biologics or complex therapies straight into the bloodstream thus ensuring accurate dosing with consistent therapeutic outcomes. It has been a major driving force behind market expansion trends.
Biologics and Biosimilar Market Growth:
• The requirement for specific delivery devices that ensure maintenance of both efficacy and safety during use has arisen from increased adoption rates of biosimilars and biologic drugs. They include devices that enable controlled release profiles with enhanced bioavailability specifically designed for this class of drugs hence facilitating their uptake.
Regulatory Support and Guidelines:
• Development of stringent regulatory frameworks and guidelines that place emphasis on patient safety and efficacy are shaping up these subcutaneous drug delivery devices. Consequently, they present various opportunities for market participants to enlarge their range through new formulations or device approvals in other territories.
Patient-Centric Approach:
• As a result, there is an increasing demand towards more user-friendly drug delivery options that are patient centric due to patients’ preference to self-administration at home. Healthcare providers are finding interest in low-tech subcutaneous devices which require basic training only but have features such as remote monitoring connectivity etc.
By taking advantage of these strategic growth opportunities, the subcutaneous drug delivery device market can realize its full potential and transform numerous industries through innovative advancements in drug delivery technology, enhanced patient compliance, and improved therapeutic outcomes
Subcutaneous Drug Delivery Device Market Driver and Challenges
The subcutaneous drug delivery device market plays a crucial role across pharmaceutical, biotechnology, and healthcare industries by enabling precise and convenient administration of medications. It facilitates the delivery of biologics and therapeutics for chronic conditions, supporting patient adherence and therapeutic efficacy. Moreover, advancements in device technology are enhancing usability and expanding market opportunities globally.
The factors responsible for driving the subcutaneous drug delivery device market include:
1. Patients Favor the Ease of Use and Acceptability of Subcutaneous Drug: Compared to traditional methods of administering medicines such as Intravenous injections, subcutaneous drug delivery devices offer less invasive and more convenient routes for patients. This enhances patient compliance and improves treatment outcomes.
2. Rise in Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions necessitates effective drug delivery methods. Controlled and consistent release of drugs can be achieved through sub cutaneous devices to meet demands placed by patients undergoing long-term therapies.
3. Advancements in Technology: Continuous innovation in device technology including wearable injectors, auto injectors, and microneedle patches leads to improvement in the precision, ease of use, comfort to patients associated with SCDD. These technological advancements broaden the market appeal and support administration of complex biologics/biosimilar.
4. Regulatory Support: Stringent regulatory guidelines and approvals ensure the safety, efficacy, and quality of subcutaneous drug delivery devices. Regulatory bodies provide clear pathways for device manufacturers thereby fostering confidence among healthcare providers and patients.
Challenges facing the subcutaneous drug delivery device market are:
• Device Complexity and Cost: The development and manufacture of sophisticated subcutaneous drug delivery devices can be difficult hence expensive. High production costs may limit market accessibility and affordability particularly in emerging economies
• Compatibility with Drug Formulations: Not all medications are suitable for subcutaneous delivery due to formulation challenges like viscosity stability solubility etc. For manufacturers this poses a significant hurdle ensuring compatibility between drug formulations is an ongoing challenge for researchers;
• Patient Acceptance and Training: Some patients may have concerns about self-administration or using unfamiliar devices despite the benefits. Sufficient patient education/training is needed to promote acceptance which could mean additional cost on nurses’ time resources.
• Regulatory Compliance: Adhering with changing regulatory requirements in different regions/markets may prove complex/time consuming for device manufacturers. Compliance with varied standards/guidelines adds another layer when it comes to assuring global market access and product approval.
Innovations in material science and manufacturing processes have revolutionized subcutaneous drug delivery devices, leading to increased demand. Materials like biocompatible polymers and advanced metals enhance device durability and patient comfort while ensuring drug stability. Furthermore, advancements such as 3D printing enable precise customization of devices, improving therapeutic outcomes and expanding market opportunities globally.
Subcutaneous Drug Delivery Device Market Suppliers and Their Market Shares
In this globally competitive market, several key players such as Gerresheimer., Medtronic, Ypsomed, Inc., Elcam Medical Group, Novo Nordisk etc. dominate the market and contribute to industry’s growth and innovation. These players capture maximum market share. To know the current market share of each of major players us by email at helpdesk@lucintel.com.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies subcutaneous drug delivery device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the subcutaneous drug delivery device companies profiled in this report include.
• Gerresheimer
• Medtronic
• Ypsomed
• Elcam Medical Group
• Novo Nordisk
These companies have established themselves as leaders in the subcutaneous drug delivery device market, with extensive product portfolios, global presence, and strong research and development capabilities. They continually strive to enhance their market positions through strategic partnerships, mergers and acquisitions, and product innovations.
The market share dynamics within the subcutaneous drug delivery device market are evolving, with the entry of new players and the emergence of innovative subcutaneous drug delivery device market technologies. Additionally, collaborations between material suppliers, manufacturers, and end-users are fostering technological advancements and expanding market opportunities.
Subcutaneous Drug Delivery Device Market by Segment
Major segments of segments of the subcutaneous drug delivery device market are experiencing significant growth. Several major segments of the subcutaneous drug delivery device market are indeed experiencing significant growth, driven by advancements in technology, increasing prevalence of chronic diseases, and the demand for patient-friendly drug delivery solutions. some of the key segments experiencing growth are auto injectors, pen injectors wearable injectors, implantable pumps, microneedle, and patch systems.
This subcutaneous drug delivery device market report provides a comprehensive analysis of the marketÄX%$%Xs current trends, growth drivers, challenges, and future prospects in all major segments like above. It covers various segments, including product and distribution channel. The report offers insights into regional dynamics, highlighting the major markets for subcutaneous drug delivery device and their growth potentials. The study includes trends and forecast for the global subcutaneous drug delivery device market by product, distribution channel, and region as follows:
Subcutaneous Drug Delivery Device Market by Product [Value ($B) Analysis from 2018 to 2030]:
• Prefilled Syringes
• Pen Injectors
• Auto-Injectors
• Wearable Injectors
• Needle-Free Injectors
Subcutaneous Drug Delivery Device Market by Distribution Channel [Value ($B) Analysis from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Subcutaneous Drug Delivery Device Market by Region [Value ($B) Analysis from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Features of the Global Subcutaneous Drug Delivery Device Market
• Market Size Estimates: Subcutaneous drug delivery device market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
• Segmentation Analysis: Subcutaneous drug delivery device market size by various segments, such as by product, distribution channel, and region
• Regional Analysis: Subcutaneous drug delivery device market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by product, distribution channel, and regions for the subcutaneous drug delivery device market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the subcutaneous drug delivery device market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in global subcutaneous drug delivery device markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the subcutaneous drug delivery device market size?
Answer: The global subcutaneous drug delivery device market is expected to reach an estimated $50 billion by 2030.
Q2. What is the growth forecast for subcutaneous drug delivery device market?
Answer: The global subcutaneous drug delivery device market is expected to grow with a CAGR of 11% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the subcutaneous drug delivery device market?
Answer: The major drivers for this market are increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunization campaign.
Q4. What are the major segments for subcutaneous drug delivery device market?
Answer: The future of the subcutaneous drug delivery device market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels.
Q6. Who are the key subcutaneous drug delivery device companies?
Answer: Some of the key subcutaneous drug delivery device companies are as follows:
• Gerresheimer
• Medtronic
• Ypsomed
• Elcam Medical Group
• Novo Nordisk
Q7. Which subcutaneous drug delivery device segment will be the largest in future?
Answer: Lucintel forecasts that prefilled syringes will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost-effectiveness, and high societal acceptance.
Q8. In subcutaneous drug delivery device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the subcutaneous drug delivery device market by product (prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to subcutaneous drug delivery device market or related to subcutaneous drug delivery device companies, subcutaneous drug delivery device market size, subcutaneous drug delivery device market share, subcutaneous drug delivery device analysis, subcutaneous drug delivery device market growth, subcutaneous drug delivery device market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.